Ribosome display and affinity maturation: from antibodies to single V-domains and steps towards cancer therapeutics.
Protein affinity maturation using molecular evolution techniques to produce high-affinity binding proteins is an important step in the generation of reagents for cancer diagnosis and treatment. Currently, the most commonly used molecular evolution processes involve mutation of a single gene into complex gene repertoires followed by selection from a display library. Fd-bacteriophage are the most popular display vectors, but are limited in their capacity for library presentation, speed of processing and mutation frequency. Recently, the potential of ribosome display for directed molecular evolution was recognised and developed into a rapid and simple affinity selection strategy using ribosome complexes to display antibody fragments (scFv). Ribosome display and selection has the potential to generate and display large libraries more representative of the theoretical optima for naïve repertoires (10(14)). Even more important is the application of ribosome display for the affinity maturation of individual proteins by rapid mutation and selection cycles. These display strategies can apply to other members of the immunoglobulin superfamily; for example single V-domains which have an important application in providing specific targeting to either novel or refractory cancer markers. We discuss the application of ribosome display and selection in conjunction with variable domain (CTLA-4) libraries as the first step towards this objective and review affinity maturation strategies for in vitro ribosome display systems.
CSIRO Health Sciences and Nutrition and CRC for Diagnostic Technologies, 343 Royal Parade, Parkville, 3052, Victoria, Australia. bob.irving@hsn.csiro.au
R A
RA
Irving
G
G
Coia
A
A
Roberts
S D
SD
Nuttall
P J
PJ
Hudson
D000595:Amino Acid Sequence; D000818:Animals; D000915:Antibody Affinity; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D007128:Immunoglobulin Fragments / Q000096:biosynthesis* / Q000235:genetics / Q000627:therapeutic use; D008969:Molecular Sequence Data; D009369:Neoplasms / Q000628:therapy*; D019151:Peptide Library; D014176:Protein Biosynthesis; D017510:Protein Folding; D012324:RNA-Dependent RNA Polymerase / Q000378:metabolism; D012270:Ribosomes / Q000378:metabolism*; D014158:Transcription, Genetic
D007128:Immunoglobulin Fragments; D019151:Peptide Library; C055966:immunoglobulin Fv; D012324:RNA-Dependent RNA Polymerase